Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Nippon Shinyaku Co., Ltd. ( (JP:4516) ) just unveiled an update.
Nippon Shinyaku Co., Ltd. reported its consolidated financial results for the first quarter ended June 30, 2025, showing a slight increase in revenue but a decline in operating profit and net income compared to the previous year. The company maintains its dividend forecast for the year ending March 31, 2026, indicating a stable outlook despite the current financial challenges.
The most recent analyst rating on (JP:4516) stock is a Hold with a Yen3900.00 price target. To see the full list of analyst forecasts on Nippon Shinyaku Co., Ltd. stock, see the JP:4516 Stock Forecast page.
More about Nippon Shinyaku Co., Ltd.
Nippon Shinyaku Co., Ltd. is a company listed on the Tokyo Stock Exchange, operating in the pharmaceutical industry. The company focuses on the development and distribution of pharmaceutical products, aiming to address various medical needs and improve patient outcomes.
Average Trading Volume: 344,359
Technical Sentiment Signal: Strong Sell
Current Market Cap: Yen222.1B
See more data about 4516 stock on TipRanks’ Stock Analysis page.